NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 146 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR Evidence for the Utility of ctDNA Monitoring for Recurrence After CRC... October 3, 2024 Could proton beam therapy improve throat cancer treatment? March 15, 2021 ¿Es seguro el CBD para las personas con cáncer? August 19, 2021 Osimertinib Shows Promising Activity in Previously Untreated Patients with Metastatic NSCLC... December 19, 2023 Load more HOT NEWS Doctors Want Breast Cancer Warning Label Put On Cheese ΝΕΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ EMA Recommends Granting a Marketing Authorisation for Melphalan EMA Recommends Granting a Marketing Authorisation for Capmatinib
